Frequently Asked Questions
The market is segmented based on , By Type of Diabetes (Type-1, Type-2), Product (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), Devices (Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Device, Injection Pens, Insulin Pumps, Automated Insulin Delivery Systems), End User (Hospital, Personal Use, Clinic) - Industry Trends and Forecast to 2030.
.
The Global Diabetes Treatments Market size was valued at USD 5370.20 USD Million in 2022.
The Global Diabetes Treatments Market is projected to grow at a CAGR of 6.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Roche Products Limited, Johnson & Johnson Services , Sanofi, Novo Nordisk AS, ARKRAY USA , Bayer AG, Amylin Pharmaceuticals , Abbott, Medtronic , Teva Pharmaceuticals , Home Diagnostics , Novartis AG, Eli Lilly and Company, Merck & Co , AstraZeneca, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
